Excess liver transplant waitlist mortality for patients with primary biliary cholangitis under MELD‐Na allocation

• Published in: Clinical transplantation 2022-02, Vol.36 (2), p.e14527-n/a
• Main Authors: Zhou, Kali, Dodge, Jennifer L., Xu, Edison, Emamaullee, Juliet, Kahn, Jeffrey A.
• Format: Article
• Language: English
• Subjects: Abdomen; Adult; cholestatic liver disease; disparities; End Stage Liver Disease - surgery; Humans; Liver Cirrhosis, Biliary - surgery; Liver Transplantation; Non-alcoholic Fatty Liver Disease - etiology; Non-alcoholic Fatty Liver Disease - surgery; transplant policy; Waiting Lists
• ISSN: 0902-0063; 1399-0012
• DOI: 10.1111/ctr.14527

Background Historically, patients with primary biliary cholangitis (PBC) experience waitlist mortality and low rates of liver transplant (LT). Herein, the impact of MELD‐Na based allocation on PBC waitlist mortality was examined. Methods Adult patients with PBC were compared to those with alcohol‐related liver disease (ALD) or non‐alcoholic steatohepatitis (NASH) listed for LT from 2013 to 2019 in OPTN. Competing risk regression evaluated waitlist mortality in the MELD and MELD‐Na eras using propensity score weights. Results Overall, 1508 patients with PBC, 13581 with ALD, and 10455 with NASH were examined. In the MELD‐Na era, 24‐month cumulative incidence of waitlist mortality for PBC was 23.0% (95%CI 19.7–26.5%), ALD 13.9% (95%CI 13.1–14.8%), and NASH 20.0% (95%CI 18.9–21.2%). Using propensity score weights, adjusted risk of waitlist mortality was higher for PBC versus ALD (HR = 1.45, 95%CI 1.22–1.71) and NASH (HR = 1.32, 95%CI 1.14–1.55). Furthermore, among PBC, waitlist mortality risk per five‐point elevation in MELD‐Na (HR = 1.22, 95%CI 1.11–1.35) and Karnofsky score ≤30% (HR = 2.02, 95%CI 1.39–2.92) was significantly higher than among ALD (HR = 1.08, 95%CI 1.04–1.13; HR = 1.28, 95%CI 1.10–1.49) and NASH (HR = 1.05, 95%CI 1.00–1.09; HR = 1.16, 95%CI .99–1.37; all P‐interactions